Loading
Clinuvel Pharmaceuticals Limited Stock: price and insider trades · Australia
ISIN AU000000CUV3AU·
Clinuvel Pharmaceuticals Limited: what insiders have been doing
Clinuvel Pharmaceuticals Limited, founded in 2001, is a listed company based in Melbourne, Australia. Its directors and officers file their transactions with ASX. In the past year (18 October 2025 to 18 October 2026), 3 filings came from 3 insiders.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Across the 2,526 companies tracked on its exchange, the median is 3 filings; at 3 filings, this issuer sits right on that mark.
No insider has bought Clinuvel Pharmaceuticals Limited shares on the open market in the past twelve months.
These figures are compiled from regulatory filings published by ASX. They describe what insiders did and are not a recommendation.
Key facts
Headquarters: Melbourne, Australia · Founded: 2001
Source: Wikidata (CC0).
Insider Decl.
3
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Financial data
· cache
Last declaration on 5 October 2026
Declarations3 total
ShareASXISIN AU000000CUV3ASX:2924-03144568-3A703337
ShareASXISIN AU000000CUV3ASX:2924-03144066-3A703252
ShareASXISIN AU000000CUV3ASX:2924-03139005-3A702403
3 of 3 declarations
About Clinuvel Pharmaceuticals Limited
Clinuvel Pharmaceuticals Limited is a biopharmaceutical company focused on developing treatments for skin pigmentation disorders. It aims to provide innovative solutions for conditions such as erythropoiesis and photoprotection.
